サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1545604

ライフサイエンス・ソフトウェアの世界市場

Life Science Software

出版日
ページ情報
英文 182 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
ライフサイエンス・ソフトウェアの世界市場
出版日: 2024年09月02日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 182 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ライフサイエンス・ソフトウェアの世界市場は2030年までに150億米ドルに達する見込み

2023年に101億米ドルと推定されるライフサイエンス・ソフトウェアの世界市場は、2023年から2030年にかけてCAGR 5.9%で成長し、2030年には150億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるクラウド導入は、CAGR 6.4%を記録し、分析期間終了時には96億米ドルに達すると予測されます。オンプレミスデプロイメントセグメントの成長率は、分析期間中CAGR 4.9%と推定されます。

米国市場は推定28億米ドル、中国はCAGR 5.6％で成長予測

米国のライフサイエンス・ソフトウェア市場は2023年に28億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに24億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは5.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ5.7%と4.5%と予測されています。欧州では、ドイツがCAGR 4.7%で成長すると予測されています。

世界のライフサイエンス・ソフトウェア市場- 主要動向と促進要因のまとめ

ライフサイエンス・ソフトウェアが研究開発に欠かせなくなった理由とは？

ライフサイエンス・ソフトウェアは、現代の科学研究によって生成される膨大な量のデータを管理、分析、解釈するために必要なツールやプラットフォームを提供するため、研究開発（R&D）において不可欠なものとなりつつあります。データ管理システム、バイオインフォマティクスツール、ラボ情報管理システム（LIMS）などを含むこれらのソフトウェアソリューションは、研究者が複雑なデータセットを整理・分析し、ワークフローを合理化し、規制要件へのコンプライアンスを確保することを可能にします。ライフサイエンス業界では、データ駆動型の意思決定への依存度が高まるにつれ、大規模なデータ解析や統合に対応できる高度なソフトウェアソリューションへの需要が高まっており、ライフサイエンス・ソフトウェアは研究開発活動にとって不可欠な要素となっています。

技術の進歩はライフサイエンス・ソフトウェアをどのように強化していますか？

技術の進歩は、ライフサイエンス・ソフトウェアの機能を大幅に向上させ、よりパワフルでユーザーフレンドリーなソリューションの開発につながっています。人工知能（AI）と機械学習アルゴリズムのソフトウェアプラットフォームへの統合により、より高度なデータ分析が可能になり、研究者はこれまで発見することが困難であったパターンや洞察を発見することができます。クラウド・コンピューティングも重要な役割を果たしており、大規模なデータセットの保存と処理にスケーラブルで安全な環境を提供し、地理的に分散したチーム間でのリアルタイムのコラボレーションを可能にしています。さらに、データ可視化ツールの進歩により、研究者は複雑なデータを解釈し、研究結果を伝えることが容易になっています。このような技術革新は、ライフサイエンス業界全体で高度なソフトウェア・ソリューションの採用を促進しています。

ライフサイエンス・ソフトウェアの採用を促進する動向とは？

ライフサイエンス・ソフトウェアの採用を後押ししているのは、個別化医療への注目の高まり、ビッグデータとデータ分析の台頭、規制遵守とデータインテグリティの重視など、いくつかの重要な動向です。個人の遺伝子や分子プロファイルの分析が必要な個別化医療は、大規模なゲノムデータや臨床データを管理・分析できるソフトウェアへの需要を促進しています。また、ビッグデータとデータ分析の動向は、最新の研究によって生成された膨大な量のデータを処理・解釈できる高度なソフトウェア・ソリューションの必要性を高めています。さらに、規制遵守とデータの完全性が重視されるようになったことで、正確な記録管理とトレーサビリティを確保できるソフトウェア・ソリューションの導入が促進されています。こうした動向が、ライフサイエンス・ソフトウェア市場のダイナミックな成長に寄与しています。

ライフサイエンス・ソフトウェア市場の成長を促進する要因は？

ライフサイエンス・ソフトウェア市場の成長は、研究開発におけるデータ主導の意思決定に対する需要の増加、個別化医療の台頭、規制要件へのコンプライアンスの必要性など、いくつかの要因によってもたらされています。ゲノミクス、プロテオミクス、その他のデータ集約的な分野の拡大により、大規模なデータセットを管理・分析できるソフトウェアソリューションに対する需要が生じています。さらに、ライフサイエンス業界におけるデジタルトランスフォーメーションへのシフトは、ワークフローを合理化し効率を向上させるソフトウェアソリューションの採用を促進しています。また、研究開発活動が厳格な基準に適合しているかどうかを確認するために、データの完全性と規制遵守が重視されるようになっていることも、市場の成長に拍車をかけています。ライフサイエンス業界が進化を続ける中、先進的なソフトウェア・ソリューションへの需要が市場の持続的成長を促進すると予想されます。

調査対象企業の例（注目の14社）

  • ArisGlobal LLC
  • Ducen IT
  • DXC Technology
  • EPAM Systems, Inc.
  • Fujitsu Ltd.
  • GE Healthcare
  • HCL Technologies Ltd.
  • Instem Group of Companies
  • Medidata Solutions, Inc.
  • Oracle Corporation
  • PDS
  • SAP SE
  • SAS Institute, Inc.
  • Signiant, Inc.
  • Veeva Systems, Inc.
  • Xybion Corporation

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP13014

Global Life Science Software Market to Reach US$15.0 Billion by 2030

The global market for Life Science Software estimated at US$10.1 Billion in the year 2023, is expected to reach US$15.0 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$9.6 Billion by the end of the analysis period. Growth in the On-Premise Deployment segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 5.6% CAGR

The Life Science Software market in the U.S. is estimated at US$2.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.4 Billion by the year 2030 trailing a CAGR of 5.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.7% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global Life Science Software Market - Key Trends & Drivers Summarized

Why Is Life Science Software Becoming Essential in Research and Development?

Life science software is becoming essential in research and development (R&D) as it provides the tools and platforms necessary for managing, analyzing, and interpreting the vast amounts of data generated by modern scientific research. These software solutions, which include data management systems, bioinformatics tools, and laboratory information management systems (LIMS), enable researchers to organize and analyze complex datasets, streamline workflows, and ensure compliance with regulatory requirements. As the life sciences industry increasingly relies on data-driven decision-making, the demand for sophisticated software solutions that can handle large-scale data analysis and integration is growing, making life science software a critical component of R&D activities.

How Are Technological Advancements Enhancing Life Science Software?

Technological advancements are significantly enhancing the capabilities of life science software, leading to the development of more powerful and user-friendly solutions. The integration of artificial intelligence (AI) and machine learning algorithms into software platforms is enabling more advanced data analysis, allowing researchers to uncover patterns and insights that were previously difficult to detect. Cloud computing is also playing a key role, providing scalable and secure environments for storing and processing large datasets, and enabling real-time collaboration across geographically dispersed teams. Additionally, advancements in data visualization tools are making it easier for researchers to interpret complex data and communicate their findings. These technological innovations are driving the adoption of advanced software solutions across the life sciences industry.

What Trends Are Driving the Adoption of Life Science Software?

Several key trends are driving the adoption of life science software, including the increasing focus on personalized medicine, the rise of big data and data analytics, and the growing emphasis on regulatory compliance and data integrity. Personalized medicine, which requires the analysis of individual genetic and molecular profiles, is driving the demand for software that can manage and analyze large-scale genomic and clinical data. The trend towards big data and data analytics is also increasing the need for sophisticated software solutions that can process and interpret vast amounts of data generated by modern research. Additionally, the growing emphasis on regulatory compliance and data integrity is encouraging the adoption of software solutions that can ensure accurate record-keeping and traceability. These trends are contributing to the dynamic growth of the life science software market.

What Factors Are Driving the Growth of the Life Science Software Market?

The growth in the life science software market is driven by several factors, including the increasing demand for data-driven decision-making in research and development, the rise of personalized medicine, and the need for compliance with regulatory requirements. The expansion of genomics, proteomics, and other data-intensive fields is creating a demand for software solutions that can manage and analyze large datasets. Additionally, the shift towards digital transformation in the life sciences industry is driving the adoption of software solutions that can streamline workflows and improve efficiency. The growing emphasis on data integrity and regulatory compliance is also fueling market growth, as organizations seek to ensure that their research and development activities meet strict standards. As the life sciences industry continues to evolve, the demand for advanced software solutions is expected to drive sustained growth in the market.

Select Competitors (Total 14 Featured) -

  • ArisGlobal LLC
  • Ducen IT
  • DXC Technology
  • EPAM Systems, Inc.
  • Fujitsu Ltd.
  • GE Healthcare
  • HCL Technologies Ltd.
  • Instem Group of Companies
  • Medidata Solutions, Inc.
  • Oracle Corporation
  • PDS
  • SAP SE
  • SAS Institute, Inc.
  • Signiant, Inc.
  • Veeva Systems, Inc.
  • Xybion Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Life Science Software - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advancements in Cloud Computing Propel Adoption of SaaS Solutions in Life Sciences
    • Shift Towards Integrated and Scalable Software Expands Addressable Market
    • Rising Focus on Clinical Trial Management Drives Adoption of Advanced Software Solutions
    • Growing Demand for Digital Transformation Spurs Growth in Life Science Software
    • Technological Innovations in AI and Machine Learning Enhance Capabilities of Life Science Software
    • Expanding Use of Software in Drug Development and Pharmacovigilance Generates New Opportunities
    • Rising Importance of Software in Health Economics and Outcomes Research (HEOR) Strengthens Demand
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Life Science Software Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Life Science Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Life Science Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Life Science Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Cloud by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for On-Premise by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Life Science Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • Active Players in United States
    • TABLE 20: USA Recent Past, Current & Future Analysis for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Life Science Software by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Life Science Software by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Life Science Software by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2014, 2024 & 2030
  • CANADA
    • Active Players in Canada
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Life Science Software by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Life Science Software by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Life Science Software by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2014, 2024 & 2030
  • JAPAN
    • Life Science Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • Active Players in Japan
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Life Science Software by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Life Science Software by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Life Science Software by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2014, 2024 & 2030
  • CHINA
    • Life Science Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • Active Players in China
    • TABLE 38: China Recent Past, Current & Future Analysis for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Life Science Software by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Life Science Software by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Life Science Software by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2014, 2024 & 2030
  • EUROPE
    • Life Science Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Life Science Software by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Life Science Software by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Life Science Software by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Life Science Software by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Life Science Software by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Life Science Software by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2014, 2024 & 2030
  • FRANCE
    • Life Science Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • Active Players in France
    • TABLE 53: France Recent Past, Current & Future Analysis for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Life Science Software by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Life Science Software by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Life Science Software by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2014, 2024 & 2030
  • GERMANY
    • Life Science Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • Active Players in Germany
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Life Science Software by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Life Science Software by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Life Science Software by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2014, 2024 & 2030
  • ITALY
    • Active Players in Italy
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Life Science Software by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Life Science Software by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Life Science Software by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Life Science Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • Active Players in United Kingdom
    • TABLE 71: UK Recent Past, Current & Future Analysis for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Life Science Software by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Life Science Software by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Life Science Software by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • Active Players in Rest of Europe
    • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Rest of Europe Historic Review for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Rest of Europe 16-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Life Science Software by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Life Science Software by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Life Science Software by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Life Science Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • Active Players in Asia-Pacific
    • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Asia-Pacific Historic Review for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Asia-Pacific 16-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Software by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Life Science Software by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Life Science Software by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • Active Players in Rest of World
    • TABLE 89: Rest of World Recent Past, Current & Future Analysis for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of World Historic Review for Life Science Software by End-Use - Pharmaceuticals, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of World 16-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Life Science Software by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Life Science Software by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Life Science Software by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2014, 2024 & 2030

IV. COMPETITION